OverviewSuggest Edit

N4 Pharma (formerly known as Onzima Ventures) is a drug reformulation company. It is focused on developing and out-licensing new versions of existing and novel drugs with an unmet commercial or medical need.

TypePublic
Founded2014
HQLondon, GB
Websiten4pharma.com

Latest Updates

Employees (est.) (Feb 2020)4
Revenue (FY, 2018)£72.8 K(-33%)
Share Price (Oct 2016)£0

Key People/Management at N4 Pharma

John Chiplin

John Chiplin

Non-Executive Chairman
Nigel Theobald

Nigel Theobald

Chief Executive Officer
David Templeton

David Templeton

Technical Director
Luke Cairns

Luke Cairns

Non-Executive Director
Chris Britten

Chris Britten

Non-Executive Director
Show more

N4 Pharma Office Locations

N4 Pharma has offices in London and Derby
London, GB (HQ)
BT Centre, 81 Newgate St
Derby, GB
Weston House, 1 Glen Park Cl
Show all (2)

N4 Pharma Financials and Metrics

N4 Pharma Revenue

Embed Graph
View revenue for all periods
N4 Pharma's revenue was reported to be £72.83 k in FY, 2018
GBP

Revenue (FY, 2018)

72.8k

Gross profit (FY, 2018)

72.8k

Gross profit margin (FY, 2018), %

100%

Net income (FY, 2018)

(1.2m)

EBIT (FY, 2018)

(1.4m)

Market capitalization (14-Oct-2016)

2.3b

Closing stock price (14-Oct-2016)

0.0

EV

2.3b
N4 Pharma's current market capitalization is £2.3 b.
GBPFY, 2006FY, 2017FY, 2018

Revenue

1.4m109.9k72.8k

Cost of goods sold

372.0k

Gross profit

1.0m109.9k72.8k

Gross profit Margin, %

73%100%100%
GBPFY, 2006FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

832.0k347.0k587.0k19.8k

Accounts Receivable

134.0k329.0k23.2k

Inventories

208.0k347.0k

Current Assets

1.3m1.2m608.0k42.9k1.5m1.1m
GBPFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash From Operating Activities

(340.0k)(862.0k)(144.5k)(950.8k)(1.3m)

Cash From Investing Activities

507.0k1.1m403.0k27.7k

Cash From Financing Activities

(5.0k)(4.0k)114.1k1.9m783.4k

Net Change in Cash

162.0k240.0k(30.4k)1.3m(533.1k)
GBPY, 2018

EV/EBIT

-1.7 k x

EV/CFO

-1.7 k x

Financial Leverage

1.2 x
Show all financial metrics

N4 Pharma Online and Social Media Presence

Embed Graph

N4 Pharma Blogs

Nuvec® form and function: nanotopography matters

Over the last three decades, rapid progress in molecular biology has led to nucleic acids, such as plasmid DNA (pDNA), messenger RNA (mRNA) and, small interfering/silencing RNA (siRNA), being proposed for use as therapeutic agents. Our latest whitepaper underlines recent work in the field and detail…

N4 Pharma Frequently Asked Questions

  • When was N4 Pharma founded?

    N4 Pharma was founded in 2014.

  • Who are N4 Pharma key executives?

    N4 Pharma's key executives are John Chiplin, Nigel Theobald and David Templeton.

  • How many employees does N4 Pharma have?

    N4 Pharma has 4 employees.

  • What is N4 Pharma revenue?

    Latest N4 Pharma annual revenue is £72.8 k.

  • What is N4 Pharma revenue per employee?

    Latest N4 Pharma revenue per employee is £18.2 k.

  • Who are N4 Pharma competitors?

    Competitors of N4 Pharma include Consilient Health, Inceptua and Alera Labs.

  • Where is N4 Pharma headquarters?

    N4 Pharma headquarters is located at BT Centre, 81 Newgate St, London.

  • Where are N4 Pharma offices?

    N4 Pharma has offices in London and Derby.

  • How many offices does N4 Pharma have?

    N4 Pharma has 2 offices.